Is Univo Pharmaceuticals (TLV:UNVO) A Risky Investment?
Jan 26
UNVO Share Price Performance
₪0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
UNVO Community Narratives
There are no narratives available yet.
Univo Pharmaceuticals Ltd Key Details
Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.05
- Gross Margin
- 1.46%
- Net Profit Margin
- -73.35%
- Debt/Equity Ratio
- 193.1%
Univo Pharmaceuticals Ltd Competitors
Snowflake Analysis
About UNVO
- Founded
- 1993
- Employees
- 76
- CEO
- WebsiteView website
Univo Pharmaceuticals Ltd engages in the development, production, and supply of medical cannabis products. The company was formerly known as Di-Pharm Ltd and changed its name to Univo Pharmaceuticals Ltd in September 2018. Univo Pharmaceuticals Ltd was incorporated in 1993 and is based in Ashkelon, Israel.
Market Insight
This week, we’re going to look at the U.S. regulatory changes, how adoption has been trending, and one of the risks with the ETFs. If you want some exposure to Bitcoin, at the end, we’ll show you some different ways you can position your portfolio accordingly.
Continue reading
Israeli Market Performance
- 7 Days: 1.5%
- 3 Months: 16.3%
- 1 Year: 59.2%
- Year to Date: 27.0%
The market has climbed 1.5% in the last 7 days, lead by the Real Estate sector with a gain of 2.5%. In the last year, the market has climbed 59%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›